Home › Trials › Head & neck

Head and neck cancer

The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas

Who can joinAdults

Age18–70 years

Kind of studyPhase 3: compared with usual treatment

What it testsRadiation and a medicine

The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.

Where to go

1 hospital in India taking patients for this trial.

Nci, AiimsJhajjar, HaryanaDirections ↗

Registry summary (technical)

The aim of SWOAR TRIAL is to test sparing of Dysphagia/ Aspiration risk structures (DARS) and contra lateral submandibular gland by IMRT. HNSCC of the oropharynx, larynx and the hypopharynx treated with radical concurrent chemoradiotherapy or radiotherapy will be included in the trial. Patients will be randomized to SWOAR IMRT or standard IMRT. Swallowing function will be evaluated the MD Anderson Dysphagia Inventory (MDADI) scoring. Difference in the mean composite score of MDADI, a patient-reported outcome, at 6 months post radiotherapy is the primary outcome of the trial. Secondary Object…

Sponsor: All India Institute of Medical Sciences
NCT05187091 on ClinicalTrials.gov
Last updated on the registry 11 Sep 2026 · read by us 20 Oct 2026

Head and neck cancer

Where to go

Need help reaching the trial team? Write to us.